series-a
Stage
1
Investors
About
inBiome develops Molecular Culture technology that enables same-day identification of over 300 bacterial species directly from blood samples to accelerate diagnostics and guide treatment decisions in sepsis and other infectious diseases, including joint infections.
Explore inBiome's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.